These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 33052720)

  • 41. Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm.
    Kielar A; Fowler KJ; Lewis S; Yaghmai V; Miller FH; Yarmohammadi H; Kim C; Chernyak V; Yokoo T; Meyer J; Newton I; Do RK
    Abdom Radiol (NY); 2018 Jan; 43(1):218-230. PubMed ID: 28780679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma.
    Fowler KJ; Potretzke TA; Hope TA; Costa EA; Wilson SR
    Abdom Radiol (NY); 2018 Jan; 43(1):149-157. PubMed ID: 28580538
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The adoption of LI-RADS: a survey of non-academic radiologists.
    Marks RM; Fung A; Cruite I; Blevins K; Lalani T; Horvat N; Protopapas Z; Chaudhry H; Bijan B; Shiehmorteza M; Nepal P; Tang A
    Abdom Radiol (NY); 2023 Aug; 48(8):2514-2524. PubMed ID: 37233747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 2017 Version of LI-RADS for CT and MR Imaging: An Update.
    Elsayes KM; Hooker JC; Agrons MM; Kielar AZ; Tang A; Fowler KJ; Chernyak V; Bashir MR; Kono Y; Do RK; Mitchell DG; Kamaya A; Hecht EM; Sirlin CB
    Radiographics; 2017; 37(7):1994-2017. PubMed ID: 29131761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liver imaging reporting and data system (LI-RADS) v2018: comparison between computed tomography and gadoxetic acid-enhanced magnetic resonance imaging.
    Nakao S; Tanabe M; Okada M; Furukawa M; Iida E; Miyoshi K; Matsunaga N; Ito K
    Jpn J Radiol; 2019 Sep; 37(9):651-659. PubMed ID: 31321619
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound.
    Kambadakone AR; Fung A; Gupta RT; Hope TA; Fowler KJ; Lyshchik A; Ganesan K; Yaghmai V; Guimaraes AR; Sahani DV; Miller FH
    Abdom Radiol (NY); 2018 Jan; 43(1):56-74. PubMed ID: 28940042
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LI-RADS for CT diagnosis of hepatocellular carcinoma: performance of major and ancillary features.
    Alhasan A; Cerny M; Olivié D; Billiard JS; Bergeron C; Brown K; Bodson-Clermont P; Castel H; Turcotte S; Perreault P; Tang A
    Abdom Radiol (NY); 2019 Feb; 44(2):517-528. PubMed ID: 30167771
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LI-RADS categories: concepts, definitions, and criteria.
    Santillan C; Chernyak V; Sirlin C
    Abdom Radiol (NY); 2018 Jan; 43(1):101-110. PubMed ID: 29038857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Common pitfalls when using the Liver Imaging Reporting and Data System (LI-RADS): lessons learned from a multi-year experience.
    Cannella R; Fowler KJ; Borhani AA; Minervini MI; Heller M; Furlan A
    Abdom Radiol (NY); 2019 Jan; 44(1):43-53. PubMed ID: 30073400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. LI-RADS: a glimpse into the future.
    Sirlin CB; Kielar AZ; Tang A; Bashir MR
    Abdom Radiol (NY); 2018 Jan; 43(1):231-236. PubMed ID: 29318354
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Compared with CT/MRI LI-RADS, whether CEUS LI-RADS is worth popularizing in diagnosis of hepatocellular carcinoma?-a direct head-to-head meta-analysis.
    Wang H; Cao J; Fan H; Huang J; Zhang H; Ling W
    Quant Imaging Med Surg; 2023 Aug; 13(8):4919-4932. PubMed ID: 37581040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. LI-RADS
    Chernyak V; Tang A; Flusberg M; Papadatos D; Bijan B; Kono Y; Santillan C
    Abdom Radiol (NY); 2018 Jan; 43(1):82-100. PubMed ID: 28647768
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Liver Imaging Reporting and Data System: Review of Pros and Cons.
    Terzi E; Ayuso C; Piscaglia F; Bruix J
    Semin Liver Dis; 2022 Feb; 42(1):104-111. PubMed ID: 34298576
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnostic accuracy of liver imaging reporting and data system (LI-RADS) v2014 for intrahepatic mass-forming cholangiocarcinomas in patients with chronic liver disease on gadoxetic acid-enhanced MRI.
    Joo I; Lee JM; Lee SM; Lee JS; Park JY; Han JK
    J Magn Reson Imaging; 2016 Nov; 44(5):1330-1338. PubMed ID: 27087012
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review.
    van der Pol CB; Lim CS; Sirlin CB; McGrath TA; Salameh JP; Bashir MR; Tang A; Singal AG; Costa AF; Fowler K; McInnes MDF
    Gastroenterology; 2019 Mar; 156(4):976-986. PubMed ID: 30445016
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of comparative performance of CEUS and CECT/MR LI-RADS classification: Can CEUS dichotomize LI-RADS indeterminate lesions on CT or MRI?
    Tan Z; Teoh WC; Wong KM; Wansaicheong GK; Sandrasegaran K
    Clin Imaging; 2020 Jun; 62():63-68. PubMed ID: 32070868
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic performance of intravascular perfusion based contrast-enhanced ultrasound LI-RADS in the evaluation of hepatocellular carcinoma.
    Zuo D; Yang K; Wu S
    Clin Hemorheol Microcirc; 2021; 78(4):429-437. PubMed ID: 33867358
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinicians and surgeon survey regarding current and future versions of CT/MRI LI-RADS.
    Alenazi AO; Elsayes KM; Marks RM; Yacoub JH; Hecht EM; Chernyak V; Krishna S; Surabhi V; Lee JT; Ash R; Cruite I; Kielar AZ
    Abdom Radiol (NY); 2020 Aug; 45(8):2603-2611. PubMed ID: 32342150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liver Imaging Reporting and Data System Contrast-Enhanced US Nonradiation Treatment Response Assessment Version 2024.
    Lyshchik A; Fetzer DT; Kono Y; Wilson SR; Dietrich CF; Clevert DA; Meloni MF; Jang HJ; Kim TK; Lee JM; Minami Y; Kudo M; Piscaglia F
    Radiology; 2024 May; 311(2):e232369. PubMed ID: 38805727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Retrospective comparison of EASL 2018 and LI-RADS 2018 for the noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging.
    Lee S; Kim MJ; Kim SS; Shin H; Kim DY; Choi JY; Park MS; Mitchell DG
    Hepatol Int; 2020 Jan; 14(1):70-79. PubMed ID: 31802388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.